Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

April 23, 2019

Study Completion Date

June 21, 2023

Conditions

Moderate to Severe Chronic Kidney Disease

Interventions

DRUG

ELIXCYTE

Adipose-derived stem cells (ADSCs)

Trial Locations (3)

Taipei Medical University Shuang Ho Hospital, New Taipei City

Chang Gung Memorial Hospital Linkou, Taoyuan

Taichung Veterans General Hospital, Taichung

All Listed Sponsors

lead

UnicoCell Biomed CO. LTD

INDUSTRY

NCT02933827 - Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease | Biotech Hunter | Biotech Hunter